BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3349581)

  • 1. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia.
    Belhassen B; Glick A; Laniado S
    Circulation; 1988 Apr; 77(4):795-805. PubMed ID: 3349581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clinical and electrophysiologic effects of adenosine and verapamil on termination of paroxysmal supraventricular tachycardia.
    Sethi KK; Singh B; Kalra GS; Arora R; Khalilullah M
    Indian Heart J; 1994; 46(3):141-4. PubMed ID: 7821934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate.
    Viskin S; Belhassen B; Sheps D; Laniado S
    Am J Cardiol; 1992 Oct; 70(9):879-85. PubMed ID: 1529941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous adenosine triphosphate disodium: its efficacy and electrophysiologic effects on patients with paroxysmal supraventricular tachycardias.
    Tajima T; Muramatsu T; Kanaka S; Yanagishita Y; Ide M; Dohi Y
    Pacing Clin Electrophysiol; 1986 May; 9(3):401-10. PubMed ID: 2423982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.
    DiMarco JP; Sellers TD; Berne RM; West GA; Belardinelli L
    Circulation; 1983 Dec; 68(6):1254-63. PubMed ID: 6640877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
    Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic effects of intravenous adenosine triphosphate disodium on the paroxysmal supraventricular tachycardias.
    Tajima T; Muramatsu T; Kanaka S; Yanagishita Y; Ide M; Dohi Y
    Jpn Heart J; 1985 Jan; 26(1):33-43. PubMed ID: 4009958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ; Nathan AW; Bexton RS; Spurrell RA; Camm AJ
    Am J Cardiol; 1983 Mar; 51(5):770-6. PubMed ID: 6829436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia.
    Klein GJ; Gulamhusein S; Prystowsky EN; Carruthers SG; Donner AP; Ko PT
    Am J Cardiol; 1982 Jan; 49(1):117-24. PubMed ID: 7053599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction.
    Rinne C; Sharma AD; Klein GJ; Yee R; Szabo T
    Am Heart J; 1988 May; 115(5):1042-7. PubMed ID: 3364337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of adenosine and verapamil for termination of paroxysmal junctional tachycardia.
    Garratt C; Linker N; Griffith M; Ward D; Camm AJ
    Am J Cardiol; 1989 Dec; 64(19):1310-6. PubMed ID: 2589197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
    Brandão L; de Sousa J; Barreiros MC; Vagueiro MC; Amram SS
    Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained "slow-fast" and "fast-slow" AV nodal re-entrant tachycardia in a patient with recurrent supraventricular tachycardia.
    Kerr CR
    Pacing Clin Electrophysiol; 1983 Sep; 6(5 Pt 1):972-8. PubMed ID: 6195619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous propranolol or verapamil on infant orthodromic reciprocating tachycardia.
    Silberbach M; Dunnigan A; Benson DW
    Am J Cardiol; 1989 Feb; 63(7):438-42. PubMed ID: 2916428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine triphosphate and adenosine: perspectives in the acute management of paroxysmal supraventricular tachycardia.
    Belhassen B; Pelleg A
    Clin Cardiol; 1985 Sep; 8(9):460-4. PubMed ID: 4042450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.
    Wellens HJ; Tan SL; Bär FW; Düren DR; Lie KI; Dohmen HM
    Br Heart J; 1977 Oct; 39(10):1058-66. PubMed ID: 911555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents.
    Gomes JA; Hariman RJ; Kang PS; Chowdry IH
    J Am Coll Cardiol; 1985 Jan; 5(1):45-57. PubMed ID: 3964808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B; D'Onofrio A; Cavallaro C; Musto A
    Circulation; 1988 Oct; 78(4):863-9. PubMed ID: 3168194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrioventricular node reentry: intravenous verapamil as a method of defining multiple electrophysiologic types.
    Hamer A; Peter T; Mandel W
    Am Heart J; 1983 Apr; 105(4):629-42. PubMed ID: 6837417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salutary effects of intravenous ajmaline in patients with paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways: blockade of the retrograde fast pathway.
    Sethi KK; Jaishankar S; Gupta MP
    Circulation; 1984 Nov; 70(5):876-83. PubMed ID: 6488500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.